Top biopharma execs set to appear at MAHA Summitnews2025-11-11T19:12:13+00:00November 11th, 2025|Endpoints News|
Nine takeaways from our first-ever Health Tech Daynews2025-11-11T16:39:27+00:00November 11th, 2025|Endpoints News|
CDMOs don’t expect immediate impact from ‘most favored nation’ dealsnews2025-11-11T16:04:01+00:00November 11th, 2025|Endpoints News|
Voyager, Transition Bio’s small molecule drug pact; CRISPR Therapeutics ends work on a CAR-T therapynews2025-11-11T15:41:06+00:00November 11th, 2025|Endpoints News|
KalVista defies sales expectations again for Ekterlynews2025-11-11T14:51:41+00:00November 11th, 2025|Endpoints News|
Fabric buys UCM Digital Health in fifth acquisition in three yearsnews2025-11-11T14:00:44+00:00November 11th, 2025|Endpoints News|
EnGene posts more pivotal data for bladder cancer gene therapy, plans 2026 filingnews2025-11-11T12:30:20+00:00November 11th, 2025|Endpoints News|
Neurocrine reports Phase 2 fail for depression drug it licensed from Takedanews2025-11-11T11:40:18+00:00November 11th, 2025|Endpoints News|
Jury gives Novo Nordisk a win in decade-long hemophilia fraud casenews2025-11-10T20:44:45+00:00November 10th, 2025|Endpoints News|
